| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | AETNA INC NEW | 2,991 | 336,000 | 0.55% | ||
| 52 | MEDICINES CO SR GLBL CV NT 22 | 293,000 | 333,000 | 0.54% | PRN | |
| 53 | DAVITA INC | 4,544 | 333,000 | 0.54% | ||
| 54 | ISHARES TR | 1,255 | 327,000 | 0.53% | ||
| 55 | HOLOGIC INC | 9,194 | 317,000 | 0.52% | ||
| 56 | ACORDA THERAPEUTICS INC | 11,190 | 296,000 | 0.48% | ||
| 57 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 16,848 | 267,000 | 0.43% | ||
| 58 | HORTONWORKS INC | 23,010 | 260,000 | 0.42% | ||
| 59 | DEXCOM INC | 3,798 | 258,000 | 0.42% | ||
| 60 | CLOVIS ONCOLOGY INC | 13,400 | 257,000 | 0.42% | Call | |
| 61 | KITE PHARMA INCORPORATED | 5,542 | 254,000 | 0.41% | ||
| 62 | AMSURG CORP | 3,230 | 241,000 | 0.39% | ||
| 63 | MARKETAXESS HLDGS INC | 1,819 | 227,000 | 0.37% | ||
| 64 | CBRE GROUP INC | 7,644 | 220,000 | 0.36% | ||
| 65 | AMERICAN TOWER CORP NEW | 2,136 | 219,000 | 0.36% | ||
| 66 | ALIBABA GROUP HLDG LTD | 2,769 | 219,000 | 0.36% | ||
| 67 | PIONEER NAT RES CO | 1,540 | 217,000 | 0.35% | ||
| 68 | CIRRUS LOGIC INC | 4,627 | 168,000 | 0.27% | ||
| 69 | MYOKARDIA INC | 15,500 | 166,000 | 0.27% | ||
| 70 | OREXIGEN THERAPEUTICS INC | 403,000 | 166,000 | 0.27% | PRN | |
| 71 | SPECTRANETICS CORP | 207,000 | 165,000 | 0.27% | PRN | |
| 72 | ACADIA COMPANY COM | 2,765 | 152,000 | 0.25% | ||
| 73 | SAGE THERAPEUTICS INC | 4,201 | 135,000 | 0.22% | ||
| 74 | DIMENSION THERAPEUTICS INC | 16,300 | 125,000 | 0.20% | ||
| 75 | VOYAGER THERAPEUTICS INC | 14,335 | 120,000 | 0.20% | ||
| 76 | JD COM INC | 3,985 | 106,000 | 0.17% | ||
| 77 | SPECTRANETICS CORP | 6,160 | 89,000 | 0.14% | ||
| 78 | KURA ONCOLOGY INC | 20,022 | 81,000 | 0.13% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-102550, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
